Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3075% below fair value
$0.28−0.00 (-0.94%)
Close on Nov 12, 2026Market cap $38.62MP/E –Yield –
Xtant Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Xtant Medical's ebitda for the twelve months ending Jun 30, 2026 was -$6.47M, down 244.1% year over year. For fiscal 2025 it was $12.51M. The highest annual figure on record is $12.51M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.51M | – |
| FY2024 | Dec 31, 2024 | -$7.85M | – |
| FY2023 | Dec 31, 2023 | -$6.98M | – |
| FY2022 | Dec 31, 2022 | -$5.46M | – |
| FY2021 | Dec 31, 2021 | -$2.52M | -289.9% |
| FY2020 | Dec 31, 2020 | $1.33M | +49.2% |
| FY2019 | Dec 31, 2019 | $890.00K | – |
| FY2018 | Dec 31, 2018 | -$53.49M | – |
| FY2017 | Dec 31, 2017 | -$29.43M | – |
| FY2016 | Dec 31, 2016 | -$303.39K | – |
| FY2015 | Dec 31, 2015 | -$7.19M | – |
| FY2014 | Dec 31, 2014 | -$5.31M | – |
| FY2013 | Dec 31, 2013 | -$8.25M | – |
| FY2012 | Dec 31, 2012 | -$4.16M | – |
| FY2011 | Dec 31, 2011 | -$5.70M | – |
| FY2010 | Dec 31, 2010 | -$7.93M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.66M | -249.5% |
| Q1 FY2026 | Mar 31, 2026 | -$2.39M | -211.8% |
| Q4 FY2025 | Dec 31, 2025 | $875.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $3.70M | – |
| Q2 FY2025 | Jun 30, 2025 | $5.79M | – |
| Q1 FY2025 | Mar 31, 2025 | $2.14M | – |
| Q4 FY2024 | Dec 31, 2024 | -$734.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.95M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.47M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.79M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.50M | – |
| Q2 FY2023 | Jun 30, 2023 | -$588.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.40M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$982.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.55M | -518.9% |
| Q4 FY2021 | Dec 31, 2021 | -$1.62M | -345.1% |
| Q3 FY2021 | Sep 30, 2021 | -$1.14M | -189.7% |
| Q2 FY2021 | Jun 30, 2021 | -$135.00K | -266.7% |
| Q1 FY2021 | Mar 31, 2021 | $370.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $661.00K | +35.7% |
| Q3 FY2020 | Sep 30, 2020 | $1.27M | – |
| Q2 FY2020 | Jun 30, 2020 | $81.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$678.00K | -727.8% |
| Q4 FY2019 | Dec 31, 2019 | $487.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$568.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$417.00K | – |
| Q1 FY2019 | Mar 31, 2019 | $108.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$53.08M | – |
| Q3 FY2018 | Sep 30, 2018 | -$406.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.22M | – |
| Q1 FY2018 | Mar 31, 2018 | -$71.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$23.27M | -4462.3% |
| Q3 FY2017 | Sep 30, 2017 | -$3.33M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.88M | – |
| Q1 FY2017 | Mar 31, 2017 | -$496.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $533.38K | – |
| Q3 FY2016 | Sep 30, 2016 | -$638.10K | – |
See a number that looks wrong?